alkylamides (cinchocaine) and acylamides (lidocaine) can also be considered (13) .
At present, benzocaine is recommended within the European baseline series as a screening allergen to show contact allergy to local anaesthetics. Nevertheless, its efficacy has been repeatedly questioned since the 1980s (11, 14, 15) . Several suggestions to use a caine mix (as used in the TRUE Test ® (10) have not been fully accepted (11, 16) , although this is the current practice in some countries, such as Portugal. Our study was aimed at clarifying the superiority of patch testing with a caine mix in the European baseline series, which includes two ester local anaesthetics and one amide local anaesthetic, over patch testing with the ester local anaesthetic benzocaine alone.
Material and Methods
Between 1 January 2000 and 31 December 2010, we sequentially patch tested 2736 patients with a mean age of 43.9 ± 16 years (M, 29.5%; O, 23.5%; A, 24.3%; H, 37.9%; L, 6.8%; F, 26.1%; A, 52.4%). They underwent patch testing with the Portuguese baseline series, a modified European baseline series that includes a caine mix at 10% in petrolatum (benzocaine 5% pet., tetracaine 2.5% pet., and cinchocaine 2.5% pet.; Chemotechnique Diagnostics, Vellinge, Sweden) instead of benzocaine.
Forty-six patients with a clinical history of contact dermatitis who might have used local anaesthetics, mainly with anogenital dermatitis or in an occupational setting, and 4 patients previously studied in the allergy department because of a localized oedema of the oral mucosa within 24 hr of a consultation with a dentist and who had negative test results, were simultaneously patch tested, on their first visit, with a series of local anaesthetics that included benzocaine 5% pet., tetracaine 5% pet., procaine 1% pet., amilocaine 5% pet., lidocaine 5% pet., cinchocaine 5% pet., and prilocaine 5% pet. (Chemotechnique Diagnostics). All caine mix-positive patients were offered further testing with the same series of local anaesthetics.
Patch tests were applied on the upper back for 2 days with Finn Chambers ® on Scanpor ® tape (Epitest Ltd., Oy, Finland). Readings were performed at D2 and D3 or D4, according to International Contact Dermatitis Research Group guidelines (17) , with advice for a referral reading at D7 in case of a late reaction.
Patients with positive reactions (1+ or more intense) to the caine mix or to any of the separate allergens were evaluated with regard to age, sex, dermatosis location, positive reactions to chemicals of the para-group tested in the baseline series, namely p-phenylenediamine (PPD), N -isopropyl-N -phenyl-p-phenylenediamine and parabens, and relevance of positive reactions based on medical history. 
Results
Of the 2736 patients, 110 reacted to the caine mix in the baseline series (4.0%), and 2 additional patients reacted to cinchocaine during aimed testing. In total, 112 patients (35 males and 77 females, mean age 49.7 ± 15.1 years) had at least one allergic reaction to local anaesthetics, representing 4.1% of the whole population. Of these patients, only 86 (25 males and 61 females, mean age 49.3 ± 15.1 years) were patch tested with all seven separate local anaesthetics; 84 reacted to the caine mix, and 2 were caine mix-negative but reacted to cinchocaine.
In 39.3% of caine mix-positive patients, local anaesthetics tested separately gave negative results, in 52% of those with a 1+ reaction and 48% with a 2+ or 3+ reaction. Fifty-three patients (15 males and 38 females, mean age 51.1 ± 15.3 years) had positive patch test reactions to separate local anaesthetics (61.6%). Forty-one (77.4%) reacted only to one local anaesthetic, and 12 (22.6%) had two or more positive reactions, corresponding to a total of 71 positive reactions ( Table 2) .
Reactions to cinchocaine were most common (36/71, 50.7%), followed by reactions to benzocaine (16/71, 22.5%), tetracaine, procaine, lidocaine, amilocaine, and prilocaine (Table 2) . Most reactions to cinchocaine were isolated (30/36, 83.3%), whereas more than half of benzocaine-reactive patients (9/16), 7 of 8 of tetracainereactive patients and 5 of 6 of procaine-reactive patients showed reactivity to other local anaesthetics (Table 2) .
Concerning reactivity to the different chemical groups (Tables 3 and 4 ), 14 patients reacted only to esters (26.4%), 31 only to amides (58.5%), and 8 to both groups (15.1%) ( Table 5) .
Reactivity to chemicals of the para-group (Table 6 ) was observed in 8 of 53 patients (15.1%), 7 of them with reactivity to benzocaine and/or other ester local anaesthetics. One patient with contact dermatitis caused by a temporary henna tattoo also reacted to an amide local anaesthetic, cinchocaine. One patient with anogenital dermatitis caused by cinchocaine in an -+ -C u r r e n t A n o g e n i t a l 28 50 M -+ -C u r r e n t A n o g e n i t a l 29 66 F -+ -P a s t P e n i c i l l i n H S 30 45 F -+ -P a s t P e n i c i l l i n H S 31 28 F -+ -P a s t H a n d +, positive; -, negative; F, female; HS, hypersensitivity; M, male; NA, not applicable. + ----+ -C u r r e n t A n o g e n i t a l 7 -+ ---+ -C u r r e n t A n o g e n i t a l 8 + ----+ -C u r r e n t G e n e r a l i z e d +, positive; -, negative; NA, not applicable. anti-haemorrhoid ointment had a positive PPD allergy, a probable concomitant reaction with relevance to previous hair dye allergy. Among the 53 patients with positive reactions to at least one anaesthetic, 44 (83%) were considered to be relevant, 19 (35.8%) of which with current relevance. Anogenital dermatitis was the primary site of involvement in 16 patients (30.2%). Previous exposure to local anaesthetics with past relevance was considered in 25 patients (47.2%) who were patch tested for other reasons, mainly because of hand eczema.
On comparison of the relevance of cinchocaine and benzocaine reactions, 35 of cinchocaine reactions (97.2%) were relevant, whereas relevance could be suspected in only 9 of 16 benzocaine-allergic patients (56.2%), with many reactions being explained by crossreactivity with PPD in henna tattoos or hair dye allergy (3) .
In the group of 53 patients with allergy to at least one anaesthetic, 37 did not react to benzocaine (69.8%). Thus, contact allergy to local anaesthetics would not have been diagnosed or suspected if benzocaine were the only anaesthetic tested in the baseline series, whereas only 2 of 112 patients would have been missed with use of the caine mix (1.8%).
Discussion
The 4.0% prevalence of caine mix reactivity reported here is higher than in other studies, namely those of Beck and Holden (11), with 84 of 3000 patients positive (2.8%) and Sidhu et al. (16) , with 91 of 5464 patients positive (1.7%), both using the same caine mix, and Wilkinson et al. (18) , with 26 of 1981 patients positive (1.3%), using a caine mix with higher concentrations (15% and 25%). Cinchocaine (dibucaine), which is included in the amide group that is considered to be less allergenic, was the main agent responsible for contact allergy to local anaesthetics, and so it seems to be very useful for screening for contact allergy to local anaesthetics. This is in line with recent studies in the United Kingdom and Finland (16, 18, 19) , but in contrast to older reports, where benzocaine reactivity was most prevalent (11, 20) , namely in the United Kingdom, where it represented 47.5% of positive reactions to local anaesthetics by the end of the 1980s (11). Availability and prescription habits are different between countries and are continuously changing over time, which may explain the high variability of results across the world. The anti-haemorrhoid topical treatments that are frequently used contain mainly cinchocaine, as the over-the-counter ointments Faktu ® and Nupercainal ® , and Scheriproct ® ointment, which requires a medical prescription. Others contain tetracaine (Hemofissural ® or lidocaine (Doxiproct ® and Ultraproct ® . Two patients presented with a generalized dermatitis caused by cinchocaine, probably related to systemic absorption through the rectal mucosa, as reported elsewhere (21, 22) .
Over 75% of patients reacted to a single local anaesthetic, in accordance with other studies (11, 20) . Of the patients reacting to multiple local anaesthetics, 66.7% reacted to both esters and amides, which is a lower proportion than in Warshaw's study (20) . Within the ester group, reactivity to two or three local anaesthetics could be explained by cross-reactivity, owing to the chemical similarity of these molecules. Within the amide group, as in other reports, no simultaneous reactions were observed between cinchocaine and lidocaine (13, 23, 24) , and cinchocaine-positive patients tolerated local anaesthesia with subcutaneous lidocaine, which may suggest that cinchocaine should be included in a separate subgroup within the amide local anaesthetics, as an alkylamide (13) .
Simultaneous reactivity to cinchocaine or lidocaine and an ester-type local anaesthetic, similar to that previously reported (15, 19) , may be a result of separate sensitization, because most of those patients have been exposed to multiple topical drugs. In 3 patients, we could not explain the simultaneous reactivity to ester and amide local anaesthetics.
Probable cross-reactivity between local anaesthetics and other chemicals with a para-group occurred in 8 patients, mainly within the group of benzocaine-allergic patients (37.5%), in accordance with the 33% of cases reported by Thyssen et al. (14) . In contrast, only 5.6% of cinchocaine-allergic patients showed reaction to these chemicals.
Benzocaine was once regarded as a good indicator of local anaesthetic sensitization. Nowadays, however, it is rarely used by pharmaceutical companies, whereas cinchocaine is present in many over-the-counter anogenital preparations. Benzocaine induced positive reactions in a minority of patients (18.6%), 44% of which were either not relevant or attributable to cross-reactions, suggesting, as in the study of Thyssen, that this allergen is not useful in the baseline series (14) . In contrast, cinchocaine, the main allergen responsible for caine mix reactivity, was considered to be relevant in 97.2% of cases, mainly related to anti-haemorrhoid ointments. Adding cinchocaine to benzocaine in a mix allowed the diagnosis of contact allergy to local anesthetics in 37 additional patients, most of them with relevant reactions (94.6%).
The caine mix used did not detect 2 patients with relevant reactions to cinchocaine probably because cinchocaine is tested separately at a higher concentration (5% pet). Approximately 40% of caine mix-positive patients did not react to its constituents, which might suggest false-positive reactions, even though two were still considered to be relevant. We suggest that, after a caine mix positive reaction, it is highly recommended to test caines separately before advising patients concerning avoidance of local anaesthetics.
The present study, with a significant number of patients from a single centre, has the limitation that caine mix and benzocaine were not simultaneously tested in all patients. Nevertheless, these data have shown that the caine mix detected significantly more cases of relevant contact allergy to local anaesthetics than benzocaine. Some of these were unsuspected from the clinical history, and would have been missed if benzocaine was tested alone in the baseline series. Accordingly, a caine mix containing cinchocaine could, with benefit, replace benzocaine in the European baseline series, but a multicentre study involving several clinics in Europe simultaneously patch testing caine mix and benzocaine could strongly contribute to a definite recommendation to change the baseline series.
